Prescription Drug Information: Norco (Page 7 of 7)

PRINCIPAL DISPLAY PANEL

NDC 0023-6002-01
NORCO ® 5/325
Hydrocodone Bitartrate and
Acetaminophen Tablets, USP
5 mg/325 mg
100 TabletsRx o nly

NDC 0023-6002-01
NORCO® 5/325
Hydrocodone Bitartrate and
Acetaminophen Tablets, USP
5 mg/325 mg
100 Tablets
Rx only
(click image for full-size original)

PRINCIPAL DISPLAY PANEL

NDC 0023-6021-01
NORCO ® 7.5/325
Hydrocodone Bitartrate and
Acetaminophen Tablets, USP
7.5 mg/325 mg
100 TabletsRx o nly

NDC 0023-6021-01
NORCO® 7.5/325
Hydrocodone Bitartrate and
Acetaminophen Tablets, USP
7.5 mg/325 mg
100 Tablets
Rx only
(click image for full-size original)

PRINCIPAL DISPLAY PANEL

NDC 0023-6022-01
NORCO ® 10/325
Hydrocodone Bitartrate and
Acetaminophen Tablets, USP
10 mg/325 mg
100 Tablets Rx o nly

NDC 0023-6022-01
NORCO® 10/325
Hydrocodone Bitartrate and
Acetaminophen Tablets, USP
10 mg/325 mg
100 Tablets
Rx only
(click image for full-size original)

PRINCIPAL DISPLAY PANEL

NDC 0023-6022-05
NORCO ® 10/325
Hydrocodone Bitartrate and
Acetaminophen Tablets, USP
10 mg/325 mg
500 Tablets Rx o nly

NDC 0023-6022-05
NORCO® 10/325
Hydrocodone Bitartrate and
Acetaminophen Tablets, USP
10 mg/325 mg
500 Tablets
Rx only
(click image for full-size original)

NORCO hydrocodone bitartrate and acetaminophen tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0023-6002
Route of Administration ORAL DEA Schedule CII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
HYDROCODONE BITARTRATE (HYDROCODONE) HYDROCODONE BITARTRATE 5 mg
ACETAMINOPHEN (ACETAMINOPHEN) ACETAMINOPHEN 325 mg
Inactive Ingredients
Ingredient Name Strength
CROSCARMELLOSE SODIUM
MAGNESIUM STEARATE
CELLULOSE, MICROCRYSTALLINE
Product Characteristics
Color WHITE Score 2 pieces
Shape CAPSULE (capsule-shaped) Size 14mm
Flavor Imprint Code NORCO;071
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0023-6002-01 100 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040099 05/01/2016
NORCO hydrocodone bitartrate and acetaminophen tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0023-6021
Route of Administration ORAL DEA Schedule CII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
HYDROCODONE BITARTRATE (HYDROCODONE) HYDROCODONE BITARTRATE 7.5 mg
ACETAMINOPHEN (ACETAMINOPHEN) ACETAMINOPHEN 325 mg
Inactive Ingredients
Ingredient Name Strength
CROSCARMELLOSE SODIUM
MAGNESIUM STEARATE
CELLULOSE, MICROCRYSTALLINE
Product Characteristics
Color WHITE Score 2 pieces
Shape CAPSULE (capsule-shaped) Size 14mm
Flavor Imprint Code NORCO;729
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0023-6021-01 100 TABLET in 1 BOTTLE, PLASTIC None
2 NDC:0023-6021-05 500 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040148 03/12/2013
NORCO hydrocodone bitartrate and acetaminophen tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0023-6022
Route of Administration ORAL DEA Schedule CII
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
HYDROCODONE BITARTRATE (HYDROCODONE) HYDROCODONE BITARTRATE 10 mg
ACETAMINOPHEN (ACETAMINOPHEN) ACETAMINOPHEN 325 mg
Inactive Ingredients
Ingredient Name Strength
CROSCARMELLOSE SODIUM
MAGNESIUM STEARATE
CELLULOSE, MICROCRYSTALLINE
Product Characteristics
Color WHITE Score 2 pieces
Shape CAPSULE (capsule-shaped) Size 14mm
Flavor Imprint Code NORCO;539
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0023-6022-01 100 TABLET in 1 BOTTLE, PLASTIC None
2 NDC:0023-6022-05 500 TABLET in 1 BOTTLE, PLASTIC None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040148 03/12/2013
Labeler — Allergan, Inc. (144796497)

Revised: 11/2019 Allergan, Inc.

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Medication Sections

Medication Information by RSS

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2019. All Rights Reserved.